SCHEMBL7109936

SCHEMBL7109936

C[C@H](Cl)[C@@H](C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9841402 1.00
SCHEMBL1153473 1.00
SCHEMBL7725 0.84
SCHEMBL2556849 0.84
SCHEMBL868495 0.80
SCHEMBL1705190 0.80
SCHEMBL5728116 0.77
Ethane SCHEMBL10716879 0.77
SCHEMBL5438089 0.77
SCHEMBL17222435 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1352977-A2 Novel Desulfitobacterium strain for the degradation of chloroalkenes UNIVERSITEIT GENT (BE) 2003-10-15 EP claimed
WO-2016115455-A2 6-ARYL-7-SUBSTITUTED-3-(1H-PYRAZOL-5-YL)-7H-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZINES AS INHIBITORS OF THE STAT3 PATHWAY WITH ANTI-PROLIFERATIVE ACTIVITY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-07-21 WO disclosed
EP-1352977-A2 Novel Desulfitobacterium strain for the degradation of chloroalkenes UNIVERSITEIT GENT (BE) 2003-10-15 EP disclosed